The new Tort Liability Law and the journey towards informed consent in China
Identifieur interne : 003380 ( Istex/Curation ); précédent : 003379; suivant : 003381The new Tort Liability Law and the journey towards informed consent in China
Auteurs : Xiju Zhao [Nouvelle-Zélande]Source :
- Medical law international [ 0968-5332 ] ; 2012.
Descripteurs français
- Wicri :
- geographic : Singapour.
- topic : Responsabilité civile, Soins de santé, Responsabilité, établissement hospitalier, Chirurgie.
English descriptors
- KwdEn :
- Administrative regulations, Adverse impact, Alternative treatment options, Alternative treatment plans, Angiography, Australian case, Birch, Bolam, Bolam test, Breastconserving surgery, Canadian case, Catheter angiography, Chinese courts, Chinese culture, Chinese doctors, Chinese survey, Chinese tort, Civil cases, Civil liability, Commonwealth jurisdictions, Comparative risks, Confucian society, Consent, Consent cases, Consent provisions, Consent rule, Contrary view, Court press, Critical condition, Current health condition, Defective drugs, Disability commissioner, Disclosure, Distinctiveness, Effective communication, Empirical analysis, Ethical code, Ewhc, Exercise care, Expansive approach, Experimental treatment, Expert testimony, Family members, Final version, General principles, General provisions, Great caution, Guideline, Gummow, Health care, Health care consent, Health care professionals, Health problems, High court, Hospital governors, Information disclosure, Inquisitive patient, Institutions regulation, Intermediate court, Japanese courts, Jiang right, Judgement, Judicial interpretation, Legal duty, Less treatment options, Liability, Mastectomy, Mastectomy case, Materiality, Materiality test, Medical accident, Medical accidents, Medical accidents regulation, Medical custom, Medical damage liability, Medical decisions, Medical devices, Medical disputes, Medical fault, Medical institution, Medical institutions, Medical judgement, Medical lawsuits, Medical level, Medical level theory, Medical liability, Medical malpractice, Medical negligence, Medical negligence liability, Medical opinion, Medical opinions, Medical practice, Medical practices, Medical practitioner, Medical practitioners, Medical profession, Medical professionals, Medical risks, Medical standards, Medical treatment, Milakov steven, Negligence, Negligent, Objective limb, Option, Other hand, Other information, Other jurisdictions, Other purpose, Other stipulations, Other words, Para, Particular case, Particular patient, Personal assistance service, Personal attitudes, Personal injury, Practitioner, Professional regulation, Radical mastectomy, Reasonable doctor, Reasonable patient, Reasonable person, Reproductive technologies, Responsible body, Risk tolerance levels, Rogers test, Rural areas, Separate provisions, Serious cases, Several treatment options, Significant risk, Significant risks, Singapore, Singaporean case, Special context, Special examination, Special treatment, Specific context, State council, Supreme approach, Supreme court, Surgery, Terminal disease, Therapeutic privilege, Third approach, Tong ming chuan, Tort, Tort liability, Traditional chinese, Traditional chinese medicine, Treatment activities, Treatment measures, Treatment option, Treatment options, Treatment practices, Treatment standards, Undisclosed alternative procedure, Undisclosed information, University college hospitals, Western countries, Western medicine, Western medicine practitioners, Xiju zhao, Xinjiang uygur, Zhao.
- Teeft :
- Administrative regulations, Adverse impact, Alternative treatment options, Alternative treatment plans, Angiography, Australian case, Birch, Bolam, Bolam test, Breastconserving surgery, Canadian case, Catheter angiography, Chinese courts, Chinese culture, Chinese doctors, Chinese survey, Chinese tort, Civil cases, Civil liability, Commonwealth jurisdictions, Comparative risks, Confucian society, Consent, Consent cases, Consent provisions, Consent rule, Contrary view, Court press, Critical condition, Current health condition, Defective drugs, Disability commissioner, Disclosure, Distinctiveness, Effective communication, Empirical analysis, Ethical code, Ewhc, Exercise care, Expansive approach, Experimental treatment, Expert testimony, Family members, Final version, General principles, General provisions, Great caution, Guideline, Gummow, Health care, Health care consent, Health care professionals, Health problems, High court, Hospital governors, Information disclosure, Inquisitive patient, Institutions regulation, Intermediate court, Japanese courts, Jiang right, Judgement, Judicial interpretation, Legal duty, Less treatment options, Liability, Mastectomy, Mastectomy case, Materiality, Materiality test, Medical accident, Medical accidents, Medical accidents regulation, Medical custom, Medical damage liability, Medical decisions, Medical devices, Medical disputes, Medical fault, Medical institution, Medical institutions, Medical judgement, Medical lawsuits, Medical level, Medical level theory, Medical liability, Medical malpractice, Medical negligence, Medical negligence liability, Medical opinion, Medical opinions, Medical practice, Medical practices, Medical practitioner, Medical practitioners, Medical profession, Medical professionals, Medical risks, Medical standards, Medical treatment, Milakov steven, Negligence, Negligent, Objective limb, Option, Other hand, Other information, Other jurisdictions, Other purpose, Other stipulations, Other words, Para, Particular case, Particular patient, Personal assistance service, Personal attitudes, Personal injury, Practitioner, Professional regulation, Radical mastectomy, Reasonable doctor, Reasonable patient, Reasonable person, Reproductive technologies, Responsible body, Risk tolerance levels, Rogers test, Rural areas, Separate provisions, Serious cases, Several treatment options, Significant risk, Significant risks, Singapore, Singaporean case, Special context, Special examination, Special treatment, Specific context, State council, Supreme approach, Supreme court, Surgery, Terminal disease, Therapeutic privilege, Third approach, Tong ming chuan, Tort, Tort liability, Traditional chinese, Traditional chinese medicine, Treatment activities, Treatment measures, Treatment option, Treatment options, Treatment practices, Treatment standards, Undisclosed alternative procedure, Undisclosed information, University college hospitals, Western countries, Western medicine, Western medicine practitioners, Xiju zhao, Xinjiang uygur, Zhao.
Abstract
Chinese informed consent law is in a period of fundamental transition. The recently enacted Tort Liability Law offers a new way of thinking about Chinese informed consent law in the therapeutic setting. It includes distinctive provisions relevant to informed consent, thereby creating a generous duty to inform, including a duty to inform about alternative treatment options. However, the rule as presently cast suffers from a lack of detail and clarity, fails to clearly identify the distinctiveness of the duty to disclose, and may be criticised for being all-embracing and overambitious. Nevertheless, one has reason to be optimistic about the future of Chinese informed consent law. This article offers a detailed tour through the new Tort Liability Law in the specific context of disclosure to patients and sets out certain suggestions for future development. These suggestions include that Chinese law should clearly distinguish the task of information disclosure from diagnosis and treatment, should introduce the ‘materiality’ test of information disclosure, and should also acknowledge the role of professional regulation in honouring and promoting the doctrine of informed consent. In the course of this examination, the author draws comparisons with the laws of Japan and also Commonwealth countries, including Asian common law jurisdictions, such as Singapore and Malaysia.
Url:
DOI: 10.1177/0968533212458430
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003380
Links to Exploration step
ISTEX:68B6597B5326C4F1931BE05CF1EAAC4FB946D21ALe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">The new Tort Liability Law and the journey towards informed consent in China</title>
<author wicri:is="90%"><name sortKey="Zhao, Xiju" sort="Zhao, Xiju" uniqKey="Zhao X" first="Xiju" last="Zhao">Xiju Zhao</name>
<affiliation wicri:level="1"><mods:affiliation>University of Otago, New Zealand</mods:affiliation>
<country xml:lang="fr">Nouvelle-Zélande</country>
<wicri:regionArea>University of Otago</wicri:regionArea>
</affiliation>
<affiliation><mods:affiliation>Xiju Zhao, Faculty of Law, University of Otago, PO Box 56, Dunedin 9054, New Zealand Email:</mods:affiliation>
<wicri:noCountry code="subField">Email:</wicri:noCountry>
</affiliation>
<affiliation><mods:affiliation>E-mail: xijuzhao@yahoo.com</mods:affiliation>
<wicri:noCountry code="no comma">E-mail: xijuzhao@yahoo.com</wicri:noCountry>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:68B6597B5326C4F1931BE05CF1EAAC4FB946D21A</idno>
<date when="2012" year="2012">2012</date>
<idno type="doi">10.1177/0968533212458430</idno>
<idno type="url">https://api.istex.fr/document/68B6597B5326C4F1931BE05CF1EAAC4FB946D21A/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">003380</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">003380</idno>
<idno type="wicri:Area/Istex/Curation">003380</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">The new Tort Liability Law and the journey towards informed consent in China</title>
<author wicri:is="90%"><name sortKey="Zhao, Xiju" sort="Zhao, Xiju" uniqKey="Zhao X" first="Xiju" last="Zhao">Xiju Zhao</name>
<affiliation wicri:level="1"><mods:affiliation>University of Otago, New Zealand</mods:affiliation>
<country xml:lang="fr">Nouvelle-Zélande</country>
<wicri:regionArea>University of Otago</wicri:regionArea>
</affiliation>
<affiliation><mods:affiliation>Xiju Zhao, Faculty of Law, University of Otago, PO Box 56, Dunedin 9054, New Zealand Email:</mods:affiliation>
</affiliation>
<affiliation><mods:affiliation>E-mail: xijuzhao@yahoo.com</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Medical law international</title>
<idno type="ISSN">0968-5332</idno>
<idno type="eISSN">2047-9441</idno>
<imprint><publisher>SAGE Publications</publisher>
<pubPlace>Sage UK: London, England</pubPlace>
<date type="published" when="2012">2012</date>
<biblScope unit="volume">12</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="156">156</biblScope>
<biblScope unit="page" to="187">187</biblScope>
</imprint>
<idno type="ISSN">0968-5332</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0968-5332</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Administrative regulations</term>
<term>Adverse impact</term>
<term>Alternative treatment options</term>
<term>Alternative treatment plans</term>
<term>Angiography</term>
<term>Australian case</term>
<term>Birch</term>
<term>Bolam</term>
<term>Bolam test</term>
<term>Breastconserving surgery</term>
<term>Canadian case</term>
<term>Catheter angiography</term>
<term>Chinese courts</term>
<term>Chinese culture</term>
<term>Chinese doctors</term>
<term>Chinese survey</term>
<term>Chinese tort</term>
<term>Civil cases</term>
<term>Civil liability</term>
<term>Commonwealth jurisdictions</term>
<term>Comparative risks</term>
<term>Confucian society</term>
<term>Consent</term>
<term>Consent cases</term>
<term>Consent provisions</term>
<term>Consent rule</term>
<term>Contrary view</term>
<term>Court press</term>
<term>Critical condition</term>
<term>Current health condition</term>
<term>Defective drugs</term>
<term>Disability commissioner</term>
<term>Disclosure</term>
<term>Distinctiveness</term>
<term>Effective communication</term>
<term>Empirical analysis</term>
<term>Ethical code</term>
<term>Ewhc</term>
<term>Exercise care</term>
<term>Expansive approach</term>
<term>Experimental treatment</term>
<term>Expert testimony</term>
<term>Family members</term>
<term>Final version</term>
<term>General principles</term>
<term>General provisions</term>
<term>Great caution</term>
<term>Guideline</term>
<term>Gummow</term>
<term>Health care</term>
<term>Health care consent</term>
<term>Health care professionals</term>
<term>Health problems</term>
<term>High court</term>
<term>Hospital governors</term>
<term>Information disclosure</term>
<term>Inquisitive patient</term>
<term>Institutions regulation</term>
<term>Intermediate court</term>
<term>Japanese courts</term>
<term>Jiang right</term>
<term>Judgement</term>
<term>Judicial interpretation</term>
<term>Legal duty</term>
<term>Less treatment options</term>
<term>Liability</term>
<term>Mastectomy</term>
<term>Mastectomy case</term>
<term>Materiality</term>
<term>Materiality test</term>
<term>Medical accident</term>
<term>Medical accidents</term>
<term>Medical accidents regulation</term>
<term>Medical custom</term>
<term>Medical damage liability</term>
<term>Medical decisions</term>
<term>Medical devices</term>
<term>Medical disputes</term>
<term>Medical fault</term>
<term>Medical institution</term>
<term>Medical institutions</term>
<term>Medical judgement</term>
<term>Medical lawsuits</term>
<term>Medical level</term>
<term>Medical level theory</term>
<term>Medical liability</term>
<term>Medical malpractice</term>
<term>Medical negligence</term>
<term>Medical negligence liability</term>
<term>Medical opinion</term>
<term>Medical opinions</term>
<term>Medical practice</term>
<term>Medical practices</term>
<term>Medical practitioner</term>
<term>Medical practitioners</term>
<term>Medical profession</term>
<term>Medical professionals</term>
<term>Medical risks</term>
<term>Medical standards</term>
<term>Medical treatment</term>
<term>Milakov steven</term>
<term>Negligence</term>
<term>Negligent</term>
<term>Objective limb</term>
<term>Option</term>
<term>Other hand</term>
<term>Other information</term>
<term>Other jurisdictions</term>
<term>Other purpose</term>
<term>Other stipulations</term>
<term>Other words</term>
<term>Para</term>
<term>Particular case</term>
<term>Particular patient</term>
<term>Personal assistance service</term>
<term>Personal attitudes</term>
<term>Personal injury</term>
<term>Practitioner</term>
<term>Professional regulation</term>
<term>Radical mastectomy</term>
<term>Reasonable doctor</term>
<term>Reasonable patient</term>
<term>Reasonable person</term>
<term>Reproductive technologies</term>
<term>Responsible body</term>
<term>Risk tolerance levels</term>
<term>Rogers test</term>
<term>Rural areas</term>
<term>Separate provisions</term>
<term>Serious cases</term>
<term>Several treatment options</term>
<term>Significant risk</term>
<term>Significant risks</term>
<term>Singapore</term>
<term>Singaporean case</term>
<term>Special context</term>
<term>Special examination</term>
<term>Special treatment</term>
<term>Specific context</term>
<term>State council</term>
<term>Supreme approach</term>
<term>Supreme court</term>
<term>Surgery</term>
<term>Terminal disease</term>
<term>Therapeutic privilege</term>
<term>Third approach</term>
<term>Tong ming chuan</term>
<term>Tort</term>
<term>Tort liability</term>
<term>Traditional chinese</term>
<term>Traditional chinese medicine</term>
<term>Treatment activities</term>
<term>Treatment measures</term>
<term>Treatment option</term>
<term>Treatment options</term>
<term>Treatment practices</term>
<term>Treatment standards</term>
<term>Undisclosed alternative procedure</term>
<term>Undisclosed information</term>
<term>University college hospitals</term>
<term>Western countries</term>
<term>Western medicine</term>
<term>Western medicine practitioners</term>
<term>Xiju zhao</term>
<term>Xinjiang uygur</term>
<term>Zhao</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en"><term>Administrative regulations</term>
<term>Adverse impact</term>
<term>Alternative treatment options</term>
<term>Alternative treatment plans</term>
<term>Angiography</term>
<term>Australian case</term>
<term>Birch</term>
<term>Bolam</term>
<term>Bolam test</term>
<term>Breastconserving surgery</term>
<term>Canadian case</term>
<term>Catheter angiography</term>
<term>Chinese courts</term>
<term>Chinese culture</term>
<term>Chinese doctors</term>
<term>Chinese survey</term>
<term>Chinese tort</term>
<term>Civil cases</term>
<term>Civil liability</term>
<term>Commonwealth jurisdictions</term>
<term>Comparative risks</term>
<term>Confucian society</term>
<term>Consent</term>
<term>Consent cases</term>
<term>Consent provisions</term>
<term>Consent rule</term>
<term>Contrary view</term>
<term>Court press</term>
<term>Critical condition</term>
<term>Current health condition</term>
<term>Defective drugs</term>
<term>Disability commissioner</term>
<term>Disclosure</term>
<term>Distinctiveness</term>
<term>Effective communication</term>
<term>Empirical analysis</term>
<term>Ethical code</term>
<term>Ewhc</term>
<term>Exercise care</term>
<term>Expansive approach</term>
<term>Experimental treatment</term>
<term>Expert testimony</term>
<term>Family members</term>
<term>Final version</term>
<term>General principles</term>
<term>General provisions</term>
<term>Great caution</term>
<term>Guideline</term>
<term>Gummow</term>
<term>Health care</term>
<term>Health care consent</term>
<term>Health care professionals</term>
<term>Health problems</term>
<term>High court</term>
<term>Hospital governors</term>
<term>Information disclosure</term>
<term>Inquisitive patient</term>
<term>Institutions regulation</term>
<term>Intermediate court</term>
<term>Japanese courts</term>
<term>Jiang right</term>
<term>Judgement</term>
<term>Judicial interpretation</term>
<term>Legal duty</term>
<term>Less treatment options</term>
<term>Liability</term>
<term>Mastectomy</term>
<term>Mastectomy case</term>
<term>Materiality</term>
<term>Materiality test</term>
<term>Medical accident</term>
<term>Medical accidents</term>
<term>Medical accidents regulation</term>
<term>Medical custom</term>
<term>Medical damage liability</term>
<term>Medical decisions</term>
<term>Medical devices</term>
<term>Medical disputes</term>
<term>Medical fault</term>
<term>Medical institution</term>
<term>Medical institutions</term>
<term>Medical judgement</term>
<term>Medical lawsuits</term>
<term>Medical level</term>
<term>Medical level theory</term>
<term>Medical liability</term>
<term>Medical malpractice</term>
<term>Medical negligence</term>
<term>Medical negligence liability</term>
<term>Medical opinion</term>
<term>Medical opinions</term>
<term>Medical practice</term>
<term>Medical practices</term>
<term>Medical practitioner</term>
<term>Medical practitioners</term>
<term>Medical profession</term>
<term>Medical professionals</term>
<term>Medical risks</term>
<term>Medical standards</term>
<term>Medical treatment</term>
<term>Milakov steven</term>
<term>Negligence</term>
<term>Negligent</term>
<term>Objective limb</term>
<term>Option</term>
<term>Other hand</term>
<term>Other information</term>
<term>Other jurisdictions</term>
<term>Other purpose</term>
<term>Other stipulations</term>
<term>Other words</term>
<term>Para</term>
<term>Particular case</term>
<term>Particular patient</term>
<term>Personal assistance service</term>
<term>Personal attitudes</term>
<term>Personal injury</term>
<term>Practitioner</term>
<term>Professional regulation</term>
<term>Radical mastectomy</term>
<term>Reasonable doctor</term>
<term>Reasonable patient</term>
<term>Reasonable person</term>
<term>Reproductive technologies</term>
<term>Responsible body</term>
<term>Risk tolerance levels</term>
<term>Rogers test</term>
<term>Rural areas</term>
<term>Separate provisions</term>
<term>Serious cases</term>
<term>Several treatment options</term>
<term>Significant risk</term>
<term>Significant risks</term>
<term>Singapore</term>
<term>Singaporean case</term>
<term>Special context</term>
<term>Special examination</term>
<term>Special treatment</term>
<term>Specific context</term>
<term>State council</term>
<term>Supreme approach</term>
<term>Supreme court</term>
<term>Surgery</term>
<term>Terminal disease</term>
<term>Therapeutic privilege</term>
<term>Third approach</term>
<term>Tong ming chuan</term>
<term>Tort</term>
<term>Tort liability</term>
<term>Traditional chinese</term>
<term>Traditional chinese medicine</term>
<term>Treatment activities</term>
<term>Treatment measures</term>
<term>Treatment option</term>
<term>Treatment options</term>
<term>Treatment practices</term>
<term>Treatment standards</term>
<term>Undisclosed alternative procedure</term>
<term>Undisclosed information</term>
<term>University college hospitals</term>
<term>Western countries</term>
<term>Western medicine</term>
<term>Western medicine practitioners</term>
<term>Xiju zhao</term>
<term>Xinjiang uygur</term>
<term>Zhao</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Singapour</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Responsabilité civile</term>
<term>Soins de santé</term>
<term>Responsabilité</term>
<term>établissement hospitalier</term>
<term>Chirurgie</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Chinese informed consent law is in a period of fundamental transition. The recently enacted Tort Liability Law offers a new way of thinking about Chinese informed consent law in the therapeutic setting. It includes distinctive provisions relevant to informed consent, thereby creating a generous duty to inform, including a duty to inform about alternative treatment options. However, the rule as presently cast suffers from a lack of detail and clarity, fails to clearly identify the distinctiveness of the duty to disclose, and may be criticised for being all-embracing and overambitious. Nevertheless, one has reason to be optimistic about the future of Chinese informed consent law. This article offers a detailed tour through the new Tort Liability Law in the specific context of disclosure to patients and sets out certain suggestions for future development. These suggestions include that Chinese law should clearly distinguish the task of information disclosure from diagnosis and treatment, should introduce the ‘materiality’ test of information disclosure, and should also acknowledge the role of professional regulation in honouring and promoting the doctrine of informed consent. In the course of this examination, the author draws comparisons with the laws of Japan and also Commonwealth countries, including Asian common law jurisdictions, such as Singapore and Malaysia.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/EdenteV2/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003380 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 003380 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= EdenteV2 |flux= Istex |étape= Curation |type= RBID |clé= ISTEX:68B6597B5326C4F1931BE05CF1EAAC4FB946D21A |texte= The new Tort Liability Law and the journey towards informed consent in China }}
![]() | This area was generated with Dilib version V0.6.32. | ![]() |